Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

ConditionsDexmedetomidine Adjuvant Bupivacaine Scalp Block Postoperative Pain Craniotomy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorAin Shams University

About this trial

This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.

Eligibility criteria

Qualifiers

Age from 18 to 65 years.

Both sexes.

American Society of Anesthesiologists (ASA) physical status I or II.

Undergoing supratentorial elective planned craniotomies.

Disqualifiers

Patients refusal.

History of known allergy to the used local anesthetic or dexmedetomidine.

Bleeding disorders.

Evidence of local infection at the site of injection.

Trial design

Treatments tested in this trial

Scalp block
Scalp block + Dexmedetomidine

Treatment groups

50 Participants

are divided into 2 treatment groups

Locations

Ain Shams University11591, Cairo Egypt

Sponsors and collaborators

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov